Endo Health gets consents to amend indentures of three notes series

By Toni Weeks

San Luis Obispo, Calif., Nov. 27 - Endo Health Solutions said it received enough consents by 5 p.m. ET on Nov. 27, the expiration date for its consent solicitation, to amend the indentures governing three series of notes.

According to a press release, the company received consents for $485,445,000, or 97.1%, of its $500 million of 7% senior notes due 2019, $393,065,000, or 98.3%, of its $400 million of 7% senior notes due 2020 and $398,145,000, or 99.5%, of its $400 million of 7¼% senior notes due 2022.

The company needed consents from holders representing a majority of the notes. As the requirement has been satisfied, Endo said it intends to enter into supplemental indentures.

Holders who validly delivered consents by the Nov. 27 expiration date will receive a consent payment of $2.50 per $1,000 principal amount of each notes series.

RBC Capital Markets (877 381-2099 or 212 618-7822) and Deutsche Bank Securities (855 287-1922 or 212 250-7527) were the solicitation agents. D.F. King & Co., Inc. (800 735-3591 or 212 269-5550) was the information, tabulation and paying agent.

Endo Health is a Malvern, Pa.-based specialty health-care company. It began the consent solicitation on Nov. 19.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.